Search Results

There are 3349 results for: content related to: Population pharmacokinetic modeling for dose setting of nonacog beta pegol (N9-GP), a glycoPEGylated recombinant factor IX

  1. Overestimation of N-glycoPEGylated factor IX activity in a one-stage factor IX clotting assay owing to silica-mediated premature conversion to activated factor IX

    Journal of Thrombosis and Haemostasis

    Volume 14, Issue 7, July 2016, Pages: 1420–1427, P. Rosén, S. Rosén, M. Ezban and E. Persson

    Version of Record online : 22 JUN 2016, DOI: 10.1111/jth.13359

  2. Factor IX-deficient plasma spiked with N9-GP behaves similarly to N9-GP post-administration clinical samples in N9-GP ELISA and FIX activity assays

    Haemophilia

    Volume 21, Issue 6, November 2015, Pages: 832–836, M. H. Sørensen, S. Andersen and M. Ezban

    Version of Record online : 30 APR 2015, DOI: 10.1111/hae.12680

  3. Measuring factor IX activity of nonacog beta pegol with commercially available one-stage clotting and chromogenic assay kits: a two-center study

    Journal of Thrombosis and Haemostasis

    Volume 14, Issue 7, July 2016, Pages: 1428–1435, A. E. Bowyer, A. Hillarp, M. Ezban, P. Persson and S. Kitchen

    Version of Record online : 13 JUN 2016, DOI: 10.1111/jth.13348

  4. Nonacog beta pegol in previously treated children with hemophilia B: results from an international open-label phase 3 trial

    Journal of Thrombosis and Haemostasis

    Volume 14, Issue 8, August 2016, Pages: 1521–1529, M. Carcao, M. Zak, F. Abdul Karim, H. Hanabusa, S. Kearney, M.-Y. Lu, P. Persson, S. Rangarajan and E. Santagostino

    Version of Record online : 22 JUN 2016, DOI: 10.1111/jth.13360

  5. Thrombin generation assay using factor XIa to measure factors VIII and IX and their glycoPEGylated derivatives is robust and sensitive

    Journal of Thrombosis and Haemostasis

    Volume 13, Issue 11, November 2015, Pages: 2041–2052, E. K. Waters, I. Hilden, B. B. Sørensen, M. Ezban and P. K. Holm

    Version of Record online : 1 OCT 2015, DOI: 10.1111/jth.13134

  6. A variation of the Nijmegen-Bethesda assay using heat or a novel heat/cold pretreatment for the detection of FIX inhibitors in the presence of residual FIX activity

    International Journal of Laboratory Hematology

    A. H. Millner, S. Tiefenbacher, M. Robinson and H. T. Boesen

    Version of Record online : 21 AUG 2016, DOI: 10.1111/ijlh.12552

  7. You have free access to this content
    Abstracts

    Haemophilia

    Volume 22, Issue S4, July 2016, Pages: 3–138,

    Version of Record online : 11 JUL 2016, DOI: 10.1111/hae.12980

  8. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 13, Issue S2, June 2015, Pages: 1–997,

    Version of Record online : 3 JUN 2015, DOI: 10.1111/jth.12993

  9. You have free access to this content
    Extended half-life clotting factor concentrates: results from published clinical trials

    Haemophilia

    Volume 22, Issue S5, July 2016, Pages: 25–30, G. Young and J. N. Mahlangu

    Version of Record online : 13 JUL 2016, DOI: 10.1111/hae.13028

  10. Low-factor consumption for major surgery in haemophilia B with long-acting recombinant glycoPEGylated factor IX

    Haemophilia

    M. A. Escobar, R. Tehranchi, F. A. Karim, U. Caliskan, P. Chowdary, T. Colberg, P. Giangrande, A. Giermasz, M. E. Mancuso, M. Serban, W. Tsay and J. N. Mahlangu

    Version of Record online : 1 AUG 2016, DOI: 10.1111/hae.13041

  11. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 14, Issue S1, May 2016, Pages: 1–168,

    Version of Record online : 13 MAY 2016, DOI: 10.1111/jth.13325

  12. Improvement in health-related quality of life in patients with haemophilia B treated with nonacog beta pegol, a new extended half-life recombinant FIX product

    Haemophilia

    Volume 22, Issue 4, July 2016, Pages: e267–e274, P. Chowdary, S. Kearney, A. Regnault, C. S. Hoxer and D. L. Yee

    Version of Record online : 28 JUN 2016, DOI: 10.1111/hae.12995

  13. You have free access to this content
    The hope and reality of long-acting hemophilia products

    American Journal of Hematology

    Volume 87, Issue S1, May 2012, Pages: S33–S39, Steven W. Pipe

    Version of Record online : 3 MAR 2012, DOI: 10.1002/ajh.23146

  14. Cross-linked low molecular weight glycopeptide-mediated gene delivery: Relationship between DNA metabolic stability and the level of transient gene expression in vivo

    Journal of Pharmaceutical Sciences

    Volume 90, Issue 12, December 2001, Pages: 2010–2022, Yongsheng Yang, Youmie Park, Shouchin Man, Yahong Liu and Kevin G. Rice

    Version of Record online : 20 NOV 2001, DOI: 10.1002/jps.1152

  15. Correlation between FIX genotype and pharmacokinetics of Nonacog alpha according to a multicentre Italian study

    Haemophilia

    Volume 22, Issue 4, July 2016, Pages: 537–542, M. Morfini, A. Dragani, E. Paladino, P. Radossi, G. Di Minno, M. G. Mazzucconi, G. Rossetti, G. Barillari, M. Napolitano and G. Tagariello

    Version of Record online : 14 MAR 2016, DOI: 10.1111/hae.12916

  16. You have free access to this content
    Poster Presentation

    Haemophilia

    Volume 21, Issue S2, February 2015, Pages: 14–94,

    Version of Record online : 25 JAN 2015, DOI: 10.1111/hae.12625

  17. Role of enhanced half-life factor VIII and IX in the treatment of haemophilia

    British Journal of Haematology

    Volume 169, Issue 6, June 2015, Pages: 768–776, Ali J. Mahdi, Samya G. Obaji and Peter W. Collins

    Version of Record online : 7 MAR 2015, DOI: 10.1111/bjh.13360

  18. THSNA 2016 Summit Abstract Proceedings

    American Journal of Hematology

    Volume 91, Issue 9, September 2016, Pages: E363–E430,

    Version of Record online : 20 JUL 2016, DOI: 10.1002/ajh.24471

  19. You have free access to this content
    Abstracts

    Haemophilia

    Volume 18, Issue s3, July 2012, Pages: 1–208,

    Version of Record online : 18 JUN 2012, DOI: 10.1111/j.1365-2516.2012.02820.x

  20. Recombinant long-acting glycoPEGylated factor IX (nonacog beta pegol) in haemophilia B: assessment of target joints in multinational phase 3 clinical trials

    Haemophilia

    Volume 22, Issue 4, July 2016, Pages: 507–513, C. Negrier, G. Young, F. Abdul Karim, P. W. Collins, H. Hanabusa, T. Colberg, B. Goldman, C. E. Walsh and for the paradigm™ 2 and 4 Investigators

    Version of Record online : 3 MAR 2016, DOI: 10.1111/hae.12902